You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. PHOTOCLEAVABLE REAGENTS FOR ISOLATION OF STEM CELLS

    SBC: AMBERGEN, INC            Topic: N/A

    The isolation of stem cells is a critical technology for the treatment of a wide range of diseases. Since stem cells can proliferate and differentiate, their isolation facilitates transplantation and gene therapies as well as understanding the basic process of hematopoiesis. While progress has been made in the isolation of stem cells through biotin-avidin based immunoadsorption and fluorescence-a ...

    SBIR Phase I 1997 Department of Health and Human Services
  2. PHOTOCLEAVABLE LINKERS AND MARKERS FOR MASS SPECTROMETRY

    SBC: AMBERGEN, INC            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  3. PRENATAL DIAGNOSIS OF INHERITED BLOOD DISORDERS

    SBC: AMERICAN LABORATORY SUPPLIES            Topic: N/A

    During pregnancy small numbers of fetal erythrocytes enter the maternal circulation. Among these cells are nucleated erythrocytes called normoblasts. Genomic analysis of these normoblasts using specific probes by in situ hybridization or the polymerase chain reaction (PCR) potentially provides a non-invasive method for diagnosis of genetic defects. Because the number of fetal normoblasts among ...

    SBIR Phase I 1997 Department of Health and Human Services
  4. SELF CARE CUEING DEVICE

    SBC: AMRON CORPORATION            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  5. DETERRENT FOR ESCAPES FROM BED

    SBC: AMRON CORPORATION            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  6. Detection System to identify false medicare claims prior to payment

    SBC: Anthem Corporation            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  7. IIKEY PEPTIDE THERAPEUTICS

    SBC: ANTIGEN EXPRESS, INC.            Topic: N/A

    A new class of immunotherapeutic drugs will be designed around the IiKEY peptide to enhance or inhibit, in an MHC class II allele related manner, immune responses in several disease states. Binding of IiKEY homologs at an allosteric site alongside one end of the antigenic peptide binding groove of MHC class II molecules, induces a structural change in the MHC class II molecule to release bound pe ...

    SBIR Phase I 1997 Department of Health and Human Services
  8. TOPICAL TREATMENT OF KAPOSIS SARCOMA

    SBC: APHIOS CORPORATION            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  9. NOVEL ANTIHIV CHEMOTYPES FROM MARINE MICROORGANISMS

    SBC: APHIOS CORPORATION            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  10. IDENTIFICATION OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGENS

    SBC: Argonex, Inc.            Topic: N/A

    In the last several years there has been an explosion of information regarding the nature of peptide antigens expressed on human tumors together with class I molecules encoded in the Major Histocompatibility Complex (MHC) and recognized by cytotoxic T lymphocytes (CTL). One very successful approach aimed at the identification of these antigens, termed Direct Identification of Relevant Epitopes for ...

    SBIR Phase I 1997 Department of Health and Human Services
US Flag An Official Website of the United States Government